About West Nile Virus Envelope (E) Protein

West Nile virus (WNV) is a mosquito-borne flavivirus that can cause febrile illness, meningitis, encephalitis, and other neurological diseases in humans. The Envelope (E) protein is the major surface glycoprotein of West Nile virus and plays a critical role in viral attachment, receptor binding, membrane fusion, and host-cell entry. As the principal antigen exposed on the viral surface, the E protein is the primary target of protective and neutralizing antibody responses generated during natural infection and vaccination. Because of its essential role in viral infectivity and immune recognition, the E protein has become one of the most extensively studied antigens in West Nile virus research and vaccine development.

eEnzyme's recombinant West Nile Virus Envelope (E) Protein is expressed in mammalian cells and provides a valuable research tool for the study of viral pathogenesis, immune responses, and antiviral therapeutic development. The protein is suitable for antibody screening, vaccine research, receptor-binding studies, structural biology investigations, and immunological assay development. Researchers can utilize this recombinant antigen to investigate mechanisms of viral entry, characterize neutralizing antibody responses, and support the development of next-generation vaccines and therapeutics against West Nile virus infection.

Applications of West Nile Virus Envelope Protein

• Neutralizing antibody discovery and characterization
• West Nile virus vaccine development and evaluation
• Viral attachment and entry studies
• Receptor-binding investigations
• Structural biology and epitope mapping
• ELISA, Western blot, and immunological assays

Biological Significance of the E Protein

The West Nile virus Envelope protein functions as the primary mediator of viral entry into host cells. Following receptor attachment, the E protein undergoes conformational changes that facilitate fusion between the viral envelope and host-cell membranes, allowing infection to proceed. The protein contains multiple immunodominant and neutralizing epitopes that are recognized by protective antibodies, making it a key target for vaccine development, therapeutic antibody discovery, and diagnostic assay design. Because of its central role in both viral infection and host immune responses, the E protein remains one of the most important antigens for flavivirus research and the development of medical countermeasures against West Nile virus.